Pharmacological considerations when treating hypertensive patients for osteoarthritis

Expert Opin Pharmacother. 2022 Oct;23(15):1673-1676. doi: 10.1080/14656566.2022.2133601. Epub 2022 Oct 12.

Authors

Christopher R Piszczatoski¹, Steven M Smith²

Affiliations

¹ UF Health Physicians, University of Florida, Gainesville, FL, USA.
² Department of Pharmaceutical Outcomes & Policy, University of Florida College of Pharmacy, Gainesville, FL, USA.

PMID: 36206554
DOI: 10.1080/14656566.2022.2133601

No abstract available

Keywords: NSAID; Osteoarthritis; blood pressure; hypertension.

Publication types

Editorial

MeSH terms

Anti-Inflammatory Agents, Non-Steroidal / therapeutic use
Antihypertensive Agents / pharmacology
Antihypertensive Agents / therapeutic use
Blood Pressure
Humans
Hypertension* / complications
Hypertension* / drug therapy
Osteoarthritis* / drug therapy

Substances

Anti-Inflammatory Agents, Non-Steroidal
Antihypertensive Agents